P&G-Syntex' Aleve
This article was originally published in The Tan Sheet
Executive Summary
Press briefing to introduce "Pain Talk" educational health program is set for June 16 to coincide with the debut of the OTC version of nonsteroidal anti-inflammatory drug naproxen sodium. P&G said the launch will be supported with a comprehensive consumer and professional campaign including TV and print spots, extensive sampling and point-of-purchase activity...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning